Pharmalive - The Pulse of the Pharmaceutical Industry
Search Criteria: Search In:  
Conferences


R&D Directions Insider

Archive for March, 2009

Old MacDonald’s Pharma: Part 3

Friday, March 6th, 2009

Goats, llamas, and now chickens According to FierceBiotech, Symphogen and Origen Therapeutics are teaming up to develop a transgenic chicken that can produce recombinant human antibodies against cancer, infectious diseases, and autoimmune diseases. The chickens will be used as a live breeding ground for more complex antibody development, which is believed ...

Vertex eyeing hepatitis C franchise

Wednesday, March 4th, 2009

The evidence continues to point in that direction. The drugmaker, which is targeting a 2010 FDA filing for its promising protease inhibitor telaprevir, has bought two early-stage hepatitis C drug candidates from ViroChem Pharma Inc. for almost $377 million. Both compounds are non-nucleoside polymerase inhibitors, which Vertex plans to test ...

   
©2012 UBM Canon